Changes in aortic growth rate and factors influencing aneurysmal dilatation after uncomplicated acute type B aortic dissection.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
03 08 2022
Historique:
received: 26 10 2021
revised: 30 03 2022
accepted: 02 05 2022
pubmed: 6 5 2022
medline: 31 8 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

The aim of this study was to evaluate changes in aortic growth rate and factors influencing aneurysmal dilatation after uncomplicated acute type B aortic dissection (ABAD). Medically treated patients with uncomplicated ABAD between September 2004 and January 2020 were retrospectively reviewed. Diameters of 6 different sites in the descending aorta were measured and aortic growth rate was calculated according to the time interval. Factors associated with aneurysmal changes were also investigated. This study enrolled a total of 105 patients who underwent >2 serial computed tomography with a mean follow-up duration of 35.4 (12.1-77.4) months. The mean overall growth rates of the proximal descending thoracic aorta (DTA), mid-DTA, distal DTA, proximal abdominal aorta, maximal DTA and maximal abdominal aorta were 0.6 (1.9), 2.9 (5.2), 2.1 (4.0), 1.2 (2.2), 3.3 (5.6) and 1.4 (2.5) mm/year, respectively. The growth rate was higher at the early stage. It decreased over time. Growth rates of proximal DTA, mid-DTA, distal DTA, proximal abdominal aorta, maximal DTA, and maximal abdominal aorta within 3 months after dissection were 1.3 (9.6), 12.6 (18.2), 7.6 (11.7), 5.9 (7.5), 16.7 (19.8) and 6.8 (8.9) mm/year, respectively. More than 2 years later, they were 0.2 (0.6), 1.6 (1.6), 1.2 (1.3), 0.9 (1.4), 1.7 (1.9) and 1.2 (1.7) mm/year, respectively. Factors associated with aneurysmal changes after uncomplicated ABAD included an elliptical true lumen (odds ratio = 3.16; 95% confidence interval: 1.19-8.41; P = 0.021) and a proximal entry >10 mm (odds ratio = 3.08; 95% confidence interval: 1.09-8.69; P = 0.034) on initial computed tomography imaging. The aortic growth rate was higher immediately after uncomplicated ABAD but declined eventually. Patients with an elliptical true lumen and a large proximal entry might be good candidates for early endovascular intervention after uncomplicated ABAD.

Identifiants

pubmed: 35512382
pii: 6581081
doi: 10.1093/icvts/ivac126
pmc: PMC9419697
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

Eur J Vasc Endovasc Surg. 2017 Jun;53(6):793-801
pubmed: 28341530
Ann Thorac Surg. 2017 Jun;103(6):1878-1885
pubmed: 27993378
Ann Vasc Surg. 2018 Apr;48:133-140
pubmed: 29217443
Ann Thorac Surg. 2015 Sep;100(3):802-8; discussion 808-9
pubmed: 26209487
Eur J Cardiothorac Surg. 2021 Jan 4;59(1):65-73
pubmed: 33011773
Interact Cardiovasc Thorac Surg. 2020 Mar 1;30(3):458-464
pubmed: 31800040
J Vasc Surg. 2013 Nov;58(5):1220-5
pubmed: 23827338
Ann Thorac Surg. 2004 Oct;78(4):1268-73
pubmed: 15464484
Ann Thorac Surg. 1970 Sep;10(3):237-47
pubmed: 5458238
Circulation. 1995 Nov 1;92(9 Suppl):II107-12
pubmed: 7586392
Circulation. 2006 Jul 4;114(1 Suppl):I384-9
pubmed: 16820605
Ann Cardiothorac Surg. 2014 May;3(3):285-91
pubmed: 24967168
Circulation. 2008 Sep 30;118(14 Suppl):S167-70
pubmed: 18824750
J Am Coll Cardiol. 2007 Aug 21;50(8):799-804
pubmed: 17707186
Ann Thorac Surg. 2008 Jul;86(1):87-93; discussion 93-4
pubmed: 18573403
J Vasc Surg. 2014 Jan;59(1):96-106
pubmed: 24094903
J Am Coll Cardiol. 2016 Sep 6;68(10):1054-65
pubmed: 27585511
J Thorac Cardiovasc Surg. 1965 Jan;49:130-49
pubmed: 14261867
J Vasc Surg. 2018 Dec;68(6):1925-1935.e8
pubmed: 30115384
Circulation. 2009 Dec 22;120(25):2519-28
pubmed: 19996018
Circulation. 2004 Sep 14;110(11 Suppl 1):II256-61
pubmed: 15364872
Eur J Vasc Endovasc Surg. 2014 Oct;48(4):363-71
pubmed: 24952999
Circ Cardiovasc Interv. 2013 Aug;6(4):407-16
pubmed: 23922146
Circulation. 1999 Nov 9;100(19 Suppl):II275-80
pubmed: 10567316
Circulation. 2012 Jun 26;125(25):3133-41
pubmed: 22615344
Circulation. 2006 Nov 21;114(21):2226-31
pubmed: 17101856
J Vasc Surg. 2018 Dec;68(6):1649-1655
pubmed: 29914833

Auteurs

Jae Hang Lee (JH)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Joon Chul Jung (JC)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Bongyeon Sohn (B)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Hyoung Woo Chang (HW)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Dong Jung Kim (DJ)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Jun Sung Kim (JS)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Cheong Lim (C)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Kay-Hyun Park (KH)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH